UK markets close in 5 hours 42 minutes

ImmunoCellular Therapeutics, Ltd. (IMUC)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.21000.0000 (0.00%)
At close: 09:40AM EDT
Full screen
Loading interactive chart…
  • PR Newswire

    EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

    EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a peptide-nucleic acid-based broad spectrum immune regulating agent that acts on both key pro-inflammatory and anti-inflammatory cytokines with potential therapeutic utility in treating a variety of acute and chronic inflammatory conditions.